ZNF334 and hepatocellular carcinoma: In addition, it has been found that ZNF334 expression is downregulated in malignant tissues, and its expression is inversely correlated with clinical outcome of patients with various cancers, including hepatocellular carcinoma (HCC) [27, 28] and triple-negative breast cancer (TNBC) [19].